In Regard to Jethwa et al-Reference-Cited by-同舟云学术

In Regard to Jethwa et al

Published:2019-08 Issue:5 Volume:104 Page:1176-1177
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hannoun-Levi Jean-Michel,Hannoun Arthur

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference10 articles.

1. Three-fraction intracavitary accelerated partial breast brachytherapy: Early provider and patient-reported outcomes of a novel regimen;Jethwa;Int J Radiat Oncol Biol Phys,2019

2. New breast cancer radiotherapy technology confers higher complications and costs before effectiveness proven: A Medicare data analysis;Gold;Inquiry,2018

3. GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance;Ott;Radiother Oncol,2016

4. Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial;Immink;Ann Oncol,2012

5. Three-fraction accelerated partial breast irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: First results from the TRIUMPH-T trial;Khan;Int J Radiat Oncol Biol Phys,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial;Clinical and Translational Radiation Oncology;2021-07

2. In Reply to Hannoun-Levi and Hannoun;International Journal of Radiation Oncology*Biology*Physics;2019-08